“…Many studies have evaluated the association between SNPs in estrogen-related genes, such as CYP17 , CYP19 , CYP1A1 , CYP1B1 , COMT , GSTP1 , and ER α/β, and the risk of breast cancer, especially in postmenopausal women [14,15,16,17,18,19,20,21]. Polymorphisms in these genes have been reported to affect the regulation, transcription, and activity of the enzymes, as well as subsequent exposure to endogenous estrogen and the development of breast cancer [14].…”